Amalgamated Bank’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $831K | Sell |
40,475
-2,703
| -6% | -$61.9K | 0.01% | 1183 |
|
|
2026
Q1 | $951K | Sell |
43,178
-347
| -0.8% | -$6.04K | 0.01% | 1084 |
|
|
2025
Q4 | $513K | Sell |
43,525
-3
| -0% | -$39 | ﹤0.01% | 1313 |
|
|
2025
Q3 | $689K | Buy |
43,528
+740
| +2% | +$10.7K | ﹤0.01% | 1194 |
|
|
2025
Q2 | $490K | Sell |
42,788
-2,903
| -6% | -$32.7K | ﹤0.01% | 1291 |
|
|
2025
Q1 | $618K | Sell |
45,691
-27,023
| -37% | -$449K | 0.01% | 1184 |
|
|
2024
Q4 | $1.23M | Buy |
72,714
+3,188
| +5% | +$62K | 0.01% | 975 |
|
|
2024
Q3 | $1.41M | Sell |
69,526
-24,033
| -26% | -$491K | 0.01% | 932 |
|
|
2024
Q2 | $2.11M | Sell |
93,559
-7,826
| -8% | -$205K | 0.02% | 819 |
|
|
2024
Q1 | $2.66M | Buy |
101,385
+8,435
| +9% | +$240K | 0.02% | 748 |
|
|
2023
Q4 | $2.93M | Sell |
92,950
-4,715
| -5% | -$128K | 0.02% | 754 |
|
|
2023
Q3 | $2.74M | Buy |
97,665
+526
| +0.5% | +$18.1K | 0.02% | 739 |
|
|
2023
Q2 | $3.58M | Sell |
97,139
-9,303
| -9% | -$284K | 0.03% | 613 |
|
|
2023
Q1 | $3.19M | Sell |
106,442
-30,706
| -22% | -$1.01M | 0.03% | 663 |
|
|
2022
Q4 | $4.2M | Buy |
137,148
+22,003
| +19% | +$660K | 0.04% | 576 |
|
|
2022
Q3 | $2.84M | Sell |
115,145
-16,855
| -13% | -$556K | 0.03% | 674 |
|
|
2022
Q2 | $4.23M | Buy |
132,000
+16,752
| +15% | +$616K | 0.04% | 498 |
|
|
2022
Q1 | $3.63M | Sell |
115,248
-4,231
| -4% | -$132K | 0.03% | 660 |
|
|
2021
Q4 | $4.01M | Sell |
119,479
-22,940
| -16% | -$715K | 0.03% | 632 |
|
|
2021
Q3 | $4.14M | Sell |
142,419
-12,505
| -8% | -$405K | 0.03% | 608 |
|
|
2021
Q2 | $5.39M | Buy |
154,924
+134,531
| +660% | +$4.45M | 0.04% | 512 |
|
|
2021
Q1 | $569K | Sell |
20,393
-1,350
| -6% | -$35.9K | 0.02% | 911 |
|
|
2020
Q4 | $539K | Buy |
21,743
+64
| +0.3% | +$1.52K | 0.02% | 922 |
|
|
2020
Q3 | $453K | Sell |
21,679
-104
| -0.5% | -$2.01K | 0.02% | 896 |
|
|
2020
Q2 | $334K | Sell |
21,783
-14,194
| -39% | -$179K | 0.02% | 1048 |
|
|
2020
Q1 | $319K | Buy |
35,977
+115
| +0.3% | +$1.66K | 0.01% | 1115 |
|
|
2019
Q4 | $649K | Buy |
35,862
+2,087
| +6% | +$34.7K | 0.01% | 988 |
|
|
2019
Q3 | $505K | Sell |
33,775
-581
| -2% | -$9.45K | 0.01% | 1033 |
|
|
2019
Q2 | $825K | Sell |
34,356
-6,879
| -17% | -$203K | 0.02% | 831 |
|
|
2019
Q1 | $1.53M | Buy |
41,235
+331
| +0.8% | +$12K | 0.04% | 529 |
|
|
2018
Q4 | $1.15M | Buy |
40,904
+14,621
| +56% | +$462K | 0.03% | 592 |
|
|
2018
Q3 | $1.04M | Sell |
26,283
-17,223
| -40% | -$754K | 0.03% | 667 |
|
|
2018
Q2 | $1.93M | Buy |
43,506
+2,129
| +5% | +$106K | 0.05% | 406 |
|
|
2018
Q1 | $2.02M | Buy |
41,377
+2,512
| +6% | +$126K | 0.05% | 363 |
|
|
2017
Q4 | $1.95M | Buy |
38,865
+2,025
| +5% | +$106K | 0.05% | 365 |
|
|
2017
Q3 | $1.86M | Sell |
36,840
-1,018
| -3% | -$48K | 0.06% | 325 |
|
|
2017
Q2 | $1.44M | Buy |
37,858
+12,593
| +50% | +$497K | 0.05% | 434 |
|
|
2017
Q1 | $973K | Buy |
25,265
+927
| +4% | +$27.9K | 0.05% | 444 |
|
|
2016
Q4 | $538K | Buy |
24,338
+3,079
| +14% | +$63.2K | 0.02% | 793 |
|
|
2016
Q3 | $340K | Sell |
21,259
-2
| -0% | -$23 | 0.02% | 938 |
|
|
2016
Q2 | $250K | Buy |
+21,261
| New | +$189K | 0.01% | 1126 |
|
Other funds holding CC
PCM
PMG
FNFDCM
AFAS
Amalgamated Bank's CC Position: Q2 2026 in Review
Amalgamated Bank reduced its Chemours (CC) stake by 6.3% in Q2 2026, selling an estimated $61.9K and leaving 40,475 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #1183.
Amalgamated Bank first reported a position in CC in Q2 2016 and has held it in 41 quarters since. The position peaked at $5.39M in Q2 2021. 235 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Amalgamated Bank held 40,475 shares of Chemours worth $831K as of Q2 2026.
- Amalgamated Bank sold 2,703 Chemours shares in Q2 2026, an estimated $61.9K.
- Chemours made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1183 holding.
- Amalgamated Bank first reported a position in Chemours in Q2 2016 and has held it in 41 quarters since.
- Amalgamated Bank's Chemours position peaked at $5.39M in Q2 2021.
- 235 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.